Part 2/12:
Jermaine emphasizes that dementia isn’t solely a disease but a general term encompassing memory loss and cognitive decline severe enough to impair daily life. The most common types—Alzheimer’s disease and vascular dementia—account for approximately 90% of cases worldwide. Currently, no cure exists, but recent developments offer hope. A pivotal breakthrough is the approval in the U.S. of a new drug, "Aducanumab" (commonly referred to as the Santa Map), which targets the underlying cause—amyloid protein deposits in the brain, believed to damage neurons.